Some tumor model studies have shown the role of inflammatory mediators derived from MSCs like CXCL1, CXCL2, or CXCL12 on metastatic and invasive properties of cancer cells through activating their specific receptors like CXCR2 and CXCR4 (164, 165). Here, CXCL12 is linked to cancer.